AFO
LLY icon

Arrowroot Family Office’s Eli Lilly LLY Stock Holding History

Arrowroot Family Office’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
1,580
+78
+5% +$79.7K 0.54% 44
2026
Q1 		$1.38M Buy
1,502
+46
+3% +$46.6K 0.46% 51
2025
Q4 		$1.56M Buy
1,456
+29
+2% +$27.7K 0.57% 42
2025
Q3 		$1.09M Buy
1,427
+77
+6% +$57.3K 0.43% 53
2025
Q2 		$1.05M Buy
+1,350
New +$1.05M 0.47% 50
2024
Q4 		$1.03M Buy
1,330
+1
+0.1% +$828 0.53% 50
2024
Q3 		$1.18M Buy
1,329
+1
+0.1% +$899 0.69% 41
2024
Q2 		$1.2M Sell
1,328
-5
-0.4% -$4K 0.77% 33
2024
Q1 		$1.04M Buy
1,333
+1
+0.1% +$712 0.66% 41
2023
Q4 		$776K Buy
1,332
+1
+0.1% +$584 0.55% 49
2023
Q3 		$715K Buy
1,331
+10
+0.8% +$5.15K 0.56% 49
2023
Q2 		$619K Buy
1,321
+2
+0.2% +$839 0.47% 60
2023
Q1 		$453K Buy
+1,319
New +$445K 0.39% 67

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowroot Family Office's LLY Position: Q2 2026 in Review

Arrowroot Family Office increased its Eli Lilly (LLY) stake by 5.2% in Q2 2026, buying an estimated $79.7K and bringing the position to 1,580 shares worth $1.89M. The position accounts for 0.54% of the portfolio, ranked #44.

Arrowroot Family Office first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arrowroot Family Office held 1,580 shares of Eli Lilly worth $1.89M as of Q2 2026.
  • Arrowroot Family Office bought 78 Eli Lilly shares in Q2 2026, an estimated $79.7K.
  • Eli Lilly made up 0.54% of Arrowroot Family Office's portfolio in Q2 2026, its #44 holding.
  • Arrowroot Family Office first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arrowroot Family Office's 13F filing for Q2 2026, filed 6 Aug 2026.